Clinical Trials in India Still at Peril Due to Regulatory Burdens
This week, the Indian regulators announced reversal of a rule from 2 years ago that restricted an investigator from participating in more than 3 clinical trials at a given time. This is a very minor change that has little practical impact on the status of clinical trials in India. The clinical trial industry in India has been … Read more